An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
Study found that comprehensive genetic analysis is the most effective test for detecting familial hypercholesterolaemia in terms of sensitivity and quality-adjusted life-year (QALY) gain, and is also highly cost-effective, with Elucigene FH20 and LIPOchip also cost-effective but at the expense of large QALY losses because of inferior sensitivity compared with comprehensive genetic analysis.
1 Health Services Research Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
2 Health Economics Research Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
3 Clinical Genetics Centre, University of Aberdeen, Aberdeen, UK
4 Clinical Biochemistry Laboratory, NHS Grampian, Aberdeen, UK
* Corresponding author Email: p.sharma@abdn.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document